Somatostatin CAS:51110-01-1

Somatostatin (also known as incrementum hormone-inhibendo hormone (GHIH) aut somatotropin emissio-inhibentes factor (SRIF)) vel somatotropinum emissio hormona inhibita est peptide hormona quae systema endocrinum moderatur et afficit neurotransmissionem et proliferation cellularum per commercium cum receptoribus G dapibus-iunctatum somatostatin et inhibitio remissionis plurium hormonum secundariorum.. Somatostatin moderatur insulinum et glucagon.

Somatostatin duas formas activas productas per alterius unius preproprotein fissuram: unus of * 14 amino acida, alter of * 28 amino acida.

In omnibus vertebrates, sex inveniuntur genes somatostatin nominatae SS1, SS2, SS3, SS4, SS5, et SS6 ". Sex generum diversi cum quinque receptoribus somatostatinis diversi permittunt somatostatin magnam partem functionum possidere.. Homines tantum habent unum gene, SST.

Potest inhibere , thyroideum stimulans hormone, secreto insulin, glucagon's. potest inhibere secretionem per farinam testam et quinque acidum gastricum excitatum, pepsin et gastrin emissione inhibere. sanguis splanchnicus signanter reduci potest, reducing pressura portae, reducitur sanguis et pressura collateralis circulatio, reducuntur sanguis hepatis. minuere vesiculam pancreaticam et secretionem gastrici et extra intestini tenuioris, reducendo operationem cellae pancreaticae tutela effectus. glucagon secretio inhibitionis. gastrointestinal effusio et nutritionis munus afficere potest.

una immunditia (HPLC) 1.0%max
Amino Acidum Compositionem ± 10% theoretical
Peptide Content (N%) ≥ 80.0%
Aqua Content (Carolus Fischer) ≤ 8.0%
Acetate Content (HPIC)≤ 15.0%
MS (ESI)Congruunt
Imprimis Rotationes (20/D) -37.0~-47.0° (c = 1 1% HAc)
Missa Libra 95.0~ 105.0%